For research use only. Not for therapeutic Use.
AR Antagonist 1(CAT: I016344) is a selective androgen receptor (AR) antagonist with pivotal applications in oncology and endocrinology research. It inhibits AR signaling by competitively binding to the receptor, blocking androgen-mediated transcriptional activity. This mechanism is critical for studying hormone-dependent cancers, such as prostate cancer, and conditions like androgen insensitivity syndrome. AR Antagonist 1 supports investigations into AR-related signaling pathways, drug resistance, and the development of novel therapeutic strategies targeting AR dysregulation. Its specificity makes it an essential tool for advancing research in AR-driven pathologies and endocrine disorders.
Catalog Number | I016344 |
CAS Number | 1818885-54-9 |
Molecular Formula | C₁₅H₁₉ClN₂O |
Purity | ≥95% |
Target | Ligands for E3 Ligase |
IUPAC Name | 4-(3-amino-2,2,4,4-tetramethylcyclobutyl)oxy-2-chlorobenzonitrile |
InChI | InChI=1S/C15H19ClN2O/c1-14(2)12(18)15(3,4)13(14)19-10-6-5-9(8-17)11(16)7-10/h5-7,12-13H,18H2,1-4H3 |
InChIKey | ZMQAQKRIAFCCDB-UHFFFAOYSA-N |
SMILES | CC1(C(C(C1OC2=CC(=C(C=C2)C#N)Cl)(C)C)N)C |